Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7379755 | 1.00 | TSHR (0.54) | TSHRKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL4417689 | 0.87 | HPGD (0.51) | TSHRKDM4ESMN1; SMN2MEN1KMT2A | |
| SCHEMBL4415360 | 0.87 | ALDH1A1 (0.51) | TSHRLMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL4267988 | 0.87 | TSHR (0.54) | TSHRKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL733757 | 0.87 | ALDH1A1 (0.51) | TSHRLMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL4267985 | 0.87 | TSHR (0.54) | TSHRKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL4417687 | 0.87 | HPGD (0.51) | TSHRKDM4ESMN1; SMN2MEN1KMT2A | |
| SCHEMBL1877841 | 0.86 | TSHR (0.51) | TSHRKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL4276786 | 0.86 | TSHR (0.51) | TSHRKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL4276791 | 0.86 | TSHR (0.51) | TSHRKDM4ELMNASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6399628-B1 | ALZHEIMER'S DISEASE | ATHENA NEUROSCIENCES, INC. | 2002-06-04 | — | — | US | claimed |
| JP-2001508408-A | — | — | 2001-06-26 | — | — | JP | claimed |
| EP-0944580-A2 | N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 1999-09-29 | — | — | EP | claimed |
| WO-1998022441-A2 | N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE AND/OR ITS SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | claimed |
| JP-60109504-A | — | — | None | — | — | JP | disclosed |
| US-6399628-B1 | ALZHEIMER'S DISEASE | ATHENA NEUROSCIENCES, INC. | 2002-06-04 | — | — | US | disclosed |
| US-5965614-A | A PEPTIDE BLOCKING AGENT FOR TREATING ALZHEIMER'S DISEASE | ATHENA NEUROSCIENCES, INC. | 1999-10-12 | — | — | US | disclosed |
| EP-0944580-A2 | N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998022441-A2 | N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE AND/OR ITS SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | disclosed |
| US-4619685-A | N-SUBSTITUTED ALANINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1986-10-28 | — | — | US | disclosed |
| JP-S60109504-A | PLANT GROWTH REGULATING AGENT | NISSAN CHEM IND LTD | 1985-06-15 | — | — | JP | disclosed |